Initial investment in REMS means big pay-put for pharma, says RAPS author

from Outsourcing-Pharma Podcast · host William Reed Ltd

A bigger initial pay-out for REMS means long-term profitability for drugsmakers, says Quintiles Ed Tabor.

Episode metadata supplied by the publisher feed · Published Jun 5, 2012

Embed this episode

Attribution link and audio player

NOW PLAYING

Initial investment in REMS means big pay-put for pharma, says RAPS author

0:00 5:13

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 5 minutes long.

This episode was published on June 5, 2012.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!